newsfilter
← Latest News
GlobeNewswire·

Histogen Announces Removal of Clinical Hold by FDA for HST-003 IND to Initiate a Phase 1/2 Trial for Knee Cartilage Regeneration

Trial Initiation Anticipated in Second Quarter 2021 $2M Grant Awarded by the Department of Defense in September 2020 to Support Clinical Development SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) --...